Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Effect of hormonal contraceptive use before HIV seroconversion on viral load setpoint among women in Rakai, Uganda.

Polis CB, Gray RH, Bwanika JB, Kigozi G, Kiwanuka N, Nalugoda F, Kagaayi J, Lutalo T, Serwadda D, Wawer MJ.

J Acquir Immune Defic Syndr. 2011 Feb 1;56(2):125-30. doi: 10.1097/QAI.0b013e3181fbcc11.

2.

Effect of hormonal contraceptive use on HIV progression in female HIV seroconverters in Rakai, Uganda.

Polis CB, Wawer MJ, Kiwanuka N, Laeyendecker O, Kagaayi J, Lutalo T, Nalugoda F, Kigozi G, Serwadda D, Gray RH.

AIDS. 2010 Jul 31;24(12):1937-44. doi: 10.1097/QAD.0b013e32833b3282.

3.

Hormonal contraceptive use and HIV disease progression among women in Uganda and Zimbabwe.

Morrison CS, Chen PL, Nankya I, Rinaldi A, Van Der Pol B, Ma YR, Chipato T, Mugerwa R, Dunbar M, Arts E, Salata RA.

J Acquir Immune Defic Syndr. 2011 Jun 1;57(2):157-64. doi: 10.1097/QAI.0b013e318214ba4a.

4.

Initial plasma HIV-1 RNA levels and progression to AIDS in women and men.

Sterling TR, Vlahov D, Astemborski J, Hoover DR, Margolick JB, Quinn TC.

N Engl J Med. 2001 Mar 8;344(10):720-5.

5.

Trends and correlates of hormonal contraceptive use among HIV-infected women in Rakai, Uganda, 1994-2006.

Polis CB, Gray RH, Lutalo T, Nalugoda F, Kagaayi J, Kigozi G, Kiwanuka N, Serwadda D, Wawer MJ.

Contraception. 2011 Jun;83(6):549-55. doi: 10.1016/j.contraception.2010.10.002. Epub 2010 Dec 3.

PMID:
21570553
6.

Treatment during primary HIV infection does not lower viral set point but improves CD4 lymphocytes in an observational cohort.

Koegl C, Wolf E, Hanhoff N, Jessen H, Schewe K, Rausch M, Goelz J, Goetzenich A, Knechten H, Jaeger H, Becker W, Becker-Boost I, Berzow D, Beiniek B, Brust J, Shcuster D, Dupke S, Fenske S, Gellermann HJ, Gippert R, Hartmann P, Hintsche B, Jaeger H, Jaegel-Guedes E, Jessen H, Gölz J, Koelzsch J, Helm EB, Knecht G, Knechten H, Lochet I, Gute P, Mauruschat S, Mauss S, Miasnikov V, Mosthaf FA, Rausch M, Freiwald M, Reuter B, Schalk HM, Schappert B, Schnaitmann E, Schneider I, Schüler-Maué W, Schuler C, Seidel T, Starke W, Ulmer A, Müller M, Weitner I, Schewe K, Zamani C, Hanmond A, Ross K, Bottlaender A, Hoffmann C, Dix A, Schneidewind A, Lademann M; Ac-DAG Study Group.

Eur J Med Res. 2009 Jul 22;14(7):277-83.

7.

Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group.

Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire-Mangen F, Meehan MO, Lutalo T, Gray RH.

N Engl J Med. 2000 Mar 30;342(13):921-9.

8.

Survival of HIV-infected treatment-naive individuals with documented dates of seroconversion in Rakai, Uganda.

Lutalo T, Gray RH, Wawer M, Sewankambo N, Serwadda D, Laeyendecker O, Kiwanuka N, Nalugoda F, Kigozi G, Ndyanabo A, Bwanika JB, Reynolds SJ, Quinn T, Opendi P.

AIDS. 2007 Nov;21 Suppl 6:S15-9. doi: 10.1097/01.aids.0000299406.44775.de.

PMID:
18032934
9.

Natural history and risk factors associated with early and established HIV type 1 infection among reproductive-age women in Malawi.

Kumwenda JJ, Makanani B, Taulo F, Nkhoma C, Kafulafula G, Li Q, Kumwenda N, Taha TE.

Clin Infect Dis. 2008 Jun 15;46(12):1913-20. doi: 10.1086/588478.

10.

The HIV RNA setpoint theory revisited.

Geskus RB, Prins M, Hubert JB, Miedema F, Berkhout B, Rouzioux C, Delfraissy JF, Meyer L.

Retrovirology. 2007 Sep 21;4:65.

11.

Viral load and CD4 count dynamics after HIV-1 seroconversion in homosexual and bisexual men in Rio de Janeiro, Brazil.

Djomand G, Duerr A, Faulhaber JC, Struchiner CJ, Pacheco AG, Barroso PF, Melo MF, Schechter M.

J Acquir Immune Defic Syndr. 2006 Dec 1;43(4):401-4.

PMID:
17031316
12.
13.

Viral and host factors associated with the HIV-1 viral load setpoint in adults from Mbeya Region, Tanzania.

Saathoff E, Pritsch M, Geldmacher C, Hoffmann O, Koehler RN, Maboko L, Maganga L, Geis S, McCutchan FE, Kijak GH, Kim JH, Arroyo MA, Gerhardt M, Tovanabutra S, Robb ML, Williamson C, Michael NL, Hoelscher M.

J Acquir Immune Defic Syndr. 2010 Jul;54(3):324-30.

14.

The Contribution of Cervicovaginal Infections to the Immunomodulatory Effects of Hormonal Contraception.

Fichorova RN, Chen PL, Morrison CS, Doncel GF, Mendonca K, Kwok C, Chipato T, Salata R, Mauck C.

MBio. 2015 Sep 1;6(5):e00221-15. doi: 10.1128/mBio.00221-15.

15.

Pediatric viral human immunodeficiency virus type 1 RNA levels, timing of infection, and disease progression in African HIV-1-infected children.

Rouet F, Sakarovitch C, Msellati P, Elenga N, Montcho C, Viho I, Blanche S, Rouzioux C, Dabis F, Leroy V; Abidjan ANRS 049 Ditrame Study Group.

Pediatrics. 2003 Oct;112(4):e289.

PMID:
14523214
16.

Undetectable viremia without antiretroviral therapy in patients with HIV seroconversion: an uncommon phenomenon?

Madec Y, Boufassa F, Rouzioux C, Delfraissy JF, Meyer L; SEROCO Study Group.

Clin Infect Dis. 2005 May 1;40(9):1350-4. Epub 2005 Mar 31.

17.

Recent HIV-1 infection: identification of individuals with high viral load setpoint in a voluntary counselling and testing centre in rural Mozambique.

Serna-Bolea C, de Deus N, Acácio S, Muñoz J, Nhalungo D, Letang E, Alonso P, Naniche D.

PLoS One. 2012;7(2):e31859. doi: 10.1371/journal.pone.0031859. Epub 2012 Feb 21.

18.

Baseline resistance and virological outcome in patients with virological failure who start a regimen containing abacavir: EuroSIDA study.

Cabrera C, Cozzi-Lepri A, Phillips AN, Loveday C, Kirk O, Ait-Khaled M, Reiss P, Kjaer J, Ledergerber B, Lundgren JD, Clotet B, Ruiz L; EuroSIDA Study Group.

Antivir Ther. 2004 Oct;9(5):787-800.

PMID:
15535417
19.

Longitudinal serum HIV RNA quantification: correlation to viral phenotype at seroconversion and clinical outcome.

Katzenstein TL, Pedersen C, Nielsen C, Lundgren JD, Jakobsen PH, Gerstoft J.

AIDS. 1996 Feb;10(2):167-73.

PMID:
8838704
20.

Plasma viral load concentrations in women and men from different exposure categories and with known duration of HIV infection. I.CO.N.A. Study Group.

Rezza G, Lepri AC, d'Arminio Monforte A, Pezzotti P, Castelli F, Dianzani F, Lazzarin A, De Luca A, Arlotti M, Leoncini F, Manconi PE, Rizzardini G, Minoli L, Poggio A, Ippolito G, Phillips AN, Moroni M.

J Acquir Immune Defic Syndr. 2000 Sep 1;25(1):56-62.

PMID:
11064505
Items per page

Supplemental Content

Write to the Help Desk